Geron Corp. | Mutual Funds
Mutual Funds that own Geron Corp.
SPDR S&P Biotech ETF
13,432,826
7.32%
34,557
1.32%
09/06/2018
Fidelity Select Biotechnology Portfolio
9,736,665
5.3%
-2,388,094
0.61%
07/31/2018
Vanguard Total Stock Market Index Fund
4,425,177
2.41%
0
0%
07/31/2018
iShares Russell 2000 ETF
3,332,593
1.82%
-1,779
0.04%
09/06/2018
British & American Investment Trust Plc (Top 20 Holdings)
2,632,601
1.43%
-505,981
39.65%
12/31/2017
Fidelity Advisor Biotechnology Fund
2,564,067
1.4%
-1,095,814
0.51%
07/31/2018
Vanguard Extended Market Index Fund
2,289,395
1.25%
141,708
0.02%
07/31/2018
iShares Nasdaq Biotechnology ETF
1,996,884
1.09%
-26,103
0.12%
09/06/2018
iShares Russell 2000 Growth ETF
1,549,615
0.84%
0
0.08%
09/06/2018
Fidelity Spartan Extended Market Index Fund
784,613
0.43%
0
0.02%
07/31/2018
| Address |
149 Commonwealth Drive
Menlo Park California 94025
United States
|
|
Employees
|
- |
| Website |
http://www.geron.com |
| Updated |
07/08/2019 |
| Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. The company was founded by Michael D. |
